130 related articles for article (PubMed ID: 31446731)
21. Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma.
Cao C; Hu Q; Chen X
Head Neck; 2018 Mar; 40(3):590-595. PubMed ID: 29155480
[TBL] [Abstract][Full Text] [Related]
22. Treatment outcome with brachytherapy for recurrent nasopharyngeal carcinoma.
Cheah SK; Lau FN; Yusof MM; Phua VC
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6513-8. PubMed ID: 24377559
[TBL] [Abstract][Full Text] [Related]
23. Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy.
Liu B; Tan Z; Jiang Y; Chen Y; Chen Y; Ling K
J BUON; 2018; 23(6):1671-1678. PubMed ID: 30610793
[TBL] [Abstract][Full Text] [Related]
24. The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients.
Shuang H; Feng J; Caineng C; Qifeng J; Tin J; Yuanyuan C; Xiaozhong C
Clin Transl Oncol; 2019 Feb; 21(2):213-219. PubMed ID: 29943267
[TBL] [Abstract][Full Text] [Related]
25. Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
Wu MY; He XY; Hu CS
PLoS One; 2016; 11(4):e0154501. PubMed ID: 27119991
[TBL] [Abstract][Full Text] [Related]
26. [Effect of intensity modulated radiation therapy on oral mucosa and immune function in patients with nasopharyngeal carcinoma].
Liang S; Zhang N; Chen L; Zhang Y; Zheng Z; Luo W; Xu T; Lü Z; Li S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):505-510. PubMed ID: 29886466
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic sequestrectomy for skull base osteoradionecrosis in nasopharyngeal carcinoma patients: a 10‑year experience.
Liu J; Ning X; Sun X; Lu H; Gu Y; Wang D
Int J Clin Oncol; 2019 Mar; 24(3):248-255. PubMed ID: 30413913
[TBL] [Abstract][Full Text] [Related]
28. Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience.
Karam I; Huang SH; McNiven A; Su J; Xu W; Waldron J; Bayley AJ; Kim J; Cho J; Ringash J; Hope A; Chen E; Chan B; Goldstein D; O'Sullivan B; Giuliani ME
Head Neck; 2016 Apr; 38 Suppl 1():E1102-9. PubMed ID: 26451876
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic analysis of nasopharyngeal carcinoma patients with distant metastasis after curative radiotherapy].
Chen J; Zong J; Wu J; Pan J
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):216-21. PubMed ID: 25975793
[TBL] [Abstract][Full Text] [Related]
30. Correlation of quantitative parameters of magnetic resonance perfusion-weighted imaging with vascular endothelial growth factor, microvessel density and hypoxia-inducible factor-1α in nasopharyngeal carcinoma: Evaluation on radiosensitivity study.
Hu Y; E H; Yu X; Li F; Zeng L; Lu Q; Xi X; Shen L
Clin Otolaryngol; 2018 Apr; 43(2):425-433. PubMed ID: 28892580
[TBL] [Abstract][Full Text] [Related]
31. Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: a retrospective study.
Qiu S; Lu J; Zheng W; Xu L; Lin S; Huang C; Xu Y; Huang L; Pan J
BMC Cancer; 2014 Nov; 14():797. PubMed ID: 25366703
[TBL] [Abstract][Full Text] [Related]
32. Hyperfractionation for reirradiation of recurrent nasopharyngeal carcinoma.
Chua MLK; Lee VHF; Lee AWM
Lancet; 2023 Mar; 401(10380):878-879. PubMed ID: 36842441
[No Abstract] [Full Text] [Related]
33. Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis.
Leong YH; Soon YY; Lee KM; Wong LC; Tham IWK; Ho FCH
Head Neck; 2018 Mar; 40(3):622-631. PubMed ID: 29130584
[TBL] [Abstract][Full Text] [Related]
34. The angiographic and clinical outcomes of intracranial aneurysms following irradiation in patients with nasopharyngeal carcinoma: A 13-year experience and literature review.
Chan SHV; Woo YMP; Wong KSA; Chan KY; Leung KM
J Neuroradiol; 2018 Jul; 45(4):224-229. PubMed ID: 29474882
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.
Finazzi T; Rordorf T; Ikenberg K; Huber GF; Guckenberger M; Garcia Schueler HI
BMC Cancer; 2018 Apr; 18(1):395. PubMed ID: 29625593
[TBL] [Abstract][Full Text] [Related]
36. The use of MR imaging to detect residual versus recurrent nasopharyngeal carcinoma following treatment with radiation therapy.
Lin GW; Wang LX; Ji M; Qian HZ
Eur J Radiol; 2013 Dec; 82(12):2240-6. PubMed ID: 24103355
[TBL] [Abstract][Full Text] [Related]
37. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
Hwang JM; Fu KK; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
[TBL] [Abstract][Full Text] [Related]
38. Pseudoaneurysm of the external carotid artery branch following radiotherapy for nasopharyngeal carcinoma.
Li SH; Hsu SW; Wang SL; Chen HC; Huang CH
Jpn J Clin Oncol; 2007 Apr; 37(4):310-3. PubMed ID: 17553820
[TBL] [Abstract][Full Text] [Related]
39. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
Chan OS; Sze HC; Lee MC; Chan LL; Chang AT; Lee SW; Hung WM; Lee AW; Ng WT
Head Neck; 2017 Mar; 39(3):533-540. PubMed ID: 27898191
[TBL] [Abstract][Full Text] [Related]
40. Recurrence of nasopharyngeal carcinoma in the parotid region after definitive intensity-modulated radiotherapy.
Cao CN; Luo JW; Gao L; Xu GZ; Li SY; Xiao JP
J Oral Maxillofac Surg; 2013 Nov; 71(11):1993-7. PubMed ID: 24135519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
